https://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Sanofi-et-Regeneron-obtiennent-un-avis-positif-du-CHMP-pour-Kevzara-sarilumab-dans-le-traiteme-24250393/?utm_source=telegram&utm_medium=social&utm_campaign=share